For Danish hearing aid company Demant, the effect of the healthcare reform implemented in France back in January has stayed positive for longer than expected, says Demant Chief Executive Søren Nielsen in an interview with Ritzau Finans.
"A reform in France has provided our business there with particularly conducive business conditions. It's often the case that such reforms and additional funding pools leave some uncertainty about how long the effect will last. However, this has been sustained even further. Interest in getting hearing aids in France has greatly increased from this reform, and we have been very busy there and remain so," Nielsen says.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Long wait for IVDR implementation is over, putting an end to pandemic "wild west"
After prolonged debates on potential bottlenecking and supply issues, the EU’s long-awaited In Vitro Diagnostic Medical Devices Regulation comes into force on May 26.
GN purchase story is very speculative, says analyst
Competition rules could block a purchase of GN Store Nord and subsequent divestment of GN Hearing, says a Sydbank analyst on the speculative story that this might be underway.
Bavarian Nordic upgrades guidance following vaccine contract
Bavarian has been the center of attention in recent days due to its monkeypox vaccine, and the company has now secured a vaccine contract with another undisclosed country. Consequently, Bavarian has raised its expectations for the full year.
Novo Nordisk invests additional millions of dollars in new manufacturing facilities
Novo Nordisk’s DKK 17bn (USD 2.4bn) investment into upgrading and building new facilities in Kalundborg last year has now been followed by a DKK 1bn (USD 143.8m) investment in the same location.
US to start using Bavarian vaccine stockpile
In an attempt to contain a monkeypox outbreak, US authorities will start offering certain people Bavarian Nordic-developed Jynneos vaccinations against the infectious disease.
Chemist for Incoming Materials in QC Department 
Senior Chemical Safety Advisor 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Analytical Senior Scientist 
Project Manager & Scrum Master 
Scientific Writer 
Clinical Trial Administrator 
System Sales Development Consultant - Investment Projects, Merck Millipore 
(Senior) Drug Substance Specialist 
Director for innovative pre-clinical testing unit 
IRT Manager, Clinical Drug Supply 
Production Director 
Clinical Trial Manager 
Account Manager 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Senior Project Manager (GMP - Life Science)